These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12234865)
1. In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Paphitou NI; Ostrosky-Zeichner L; Paetznick VL; Rodriguez JR; Chen E; Rex JH Antimicrob Agents Chemother; 2002 Oct; 46(10):3298-300. PubMed ID: 12234865 [TBL] [Abstract][Full Text] [Related]
2. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. Espinel-Ingroff A; Rezusta A J Clin Microbiol; 2002 Jun; 40(6):2101-7. PubMed ID: 12037072 [TBL] [Abstract][Full Text] [Related]
3. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. Chryssanthou E; Cuenca-Estrella M J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895 [TBL] [Abstract][Full Text] [Related]
5. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Pfaller MA; Messer SA; Hollis RJ; Jones RN; Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586 [TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole. Pfaller MA; Diekema DJ; Messer SA; Boyken L; Huynh H; Hollis RJ J Clin Microbiol; 2002 May; 40(5):1694-7. PubMed ID: 11980944 [TBL] [Abstract][Full Text] [Related]
7. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology. Debourgogne A; de Hoog S; Lozniewski A; Machouart M Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):615-8. PubMed ID: 21744037 [No Abstract] [Full Text] [Related]
8. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Serena C; Ortoneda M; Capilla J; Pastor FJ; Sutton DA; Rinaldi MG; Guarro J Antimicrob Agents Chemother; 2003 Oct; 47(10):3161-4. PubMed ID: 14506025 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. Pfaller MA; Espinel-Ingroff A; Jones RN J Clin Microbiol; 2004 Oct; 42(10):4577-80. PubMed ID: 15472311 [TBL] [Abstract][Full Text] [Related]
10. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. Gehrt A; Peter J; Pizzo PA; Walsh TJ J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745 [TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Clancy CJ; Nguyen MH Eur J Clin Microbiol Infect Dis; 1998 Aug; 17(8):573-5. PubMed ID: 9796657 [TBL] [Abstract][Full Text] [Related]
12. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. Espinel-Ingroff A J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. Pfaller JB; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA J Clin Microbiol; 2003 Mar; 41(3):1126-9. PubMed ID: 12624040 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans. Maxwell MJ; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA J Clin Microbiol; 2003 Jan; 41(1):97-9. PubMed ID: 12517832 [TBL] [Abstract][Full Text] [Related]
15. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988 [TBL] [Abstract][Full Text] [Related]
16. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Matar MJ; Ostrosky-Zeichner L; Paetznick VL; Rodriguez JR; Chen E; Rex JH Antimicrob Agents Chemother; 2003 May; 47(5):1647-51. PubMed ID: 12709335 [TBL] [Abstract][Full Text] [Related]
17. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species. Al-Hatmi AM; Normand AC; Ranque S; Piarroux R; de Hoog GS; Meletiadis J; Meis JF Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795379 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp. Serrano MC; Ramírez M; Morilla D; Valverde A; Chávez M; Espinel-Ingroff A; Claro R; Fernández A; Almeida C; Martín-Mazuelos E J Antimicrob Chemother; 2004 May; 53(5):739-42. PubMed ID: 15056643 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. Pfaller MA; Diekema DJ; Boyken L; Messer SA; Tendolkar S; Hollis RJ J Clin Microbiol; 2003 May; 41(5):1875-80. PubMed ID: 12734220 [TBL] [Abstract][Full Text] [Related]
20. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species. Kauffman CA; Zarins LT Mycoses; 1999; 42(9-10):539-42. PubMed ID: 10592697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]